Insider · CIK 0001839162
Vickers Venture Fund VI Pte Ltd
owner
Files at AARD (Aardvark Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stockindirect: By Vickers Venture Fund VI Pte. Ltd. | +1,637,411 | - | - | 1,637,411 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stockindirect: By Vickers Venture Fund VI Pte. Ltd. | +413,491 | - | - | 2,050,902 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series A Convertible Preferred Stockderivativeindirect: By Vickers Venture Fund VI Pte. Ltd. | -13,875,429 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series B Convertible Preferred Stockderivativeindirect: By Vickers Venture Fund VI Pte. Ltd. | -3,503,919 | $0.00 | $0 | 0 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.